Cancer Advances

Manufacturing · North Carolina, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

4364 S Alston Ave Ste 105, Durham, North...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Cancer Advances

Cancer Advances is dedicated to developing therapeutics for gastrin/gastrin receptor (CCKB) producing tumors, with a focus on improving the quality of life and extending survival for patients with gastrointestinal cancers. Their lead product, Polyclonal Antibody Stimulator (PAS), is an immunomodulator that inhibits gastrin function, slowing tumor growth and altering the tumor microenvironment. The company is also exploring the synergy between PAS and PD-1 Checkpoint Inhibitors to enhance treatment efficacy. Cancer Advances aims to pioneer new medicines and redefine possibilities for cancer patients.Explore more
Cancer Advances's Social MediaPopular SearchesCancer Advances IncSIC Code 28,283NAICS Code 32,325Show more

Cancer Advances Org Chart

PhoneEmail
JW
United States flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Cancer Advances your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Cancer Advances

Compare insights from companies similar to Cancer Advances, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Cancer Advances

<$5M
11-50
Private
-
-
JW
John WingenChief Financial Officer
<$5M
11-50
Private
-
2004
Garry Redlich, Chief Executive Officer & Managing Director at Implicit Bioscience
Garry RedlichCEO & Managing Director
<$5M
1-10
Private
-
-
N/A
<$5M
11-50
Private
-
2014
CH
Cally HuCo-Founder
<$5M
1-10
Private
-
-
<$5M
1-10
Private
-
2006
SC
Sudip ChakraborttyCo-Founder & CEO
<$5M
1-10
Private
-
2013
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Cancer Advances is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Cancer Advances is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cancer Advances.

Cancer Advances Tech Stack

A closer look at the technologies used by Cancer Advances

Top Manufacturing Companies

Frequently Asked Questions Regarding Cancer Advances

What is Cancer Advances's official website?
Cancer Advances's official website is www.canceradvances.com
What is Cancer Advances's Revenue?
Cancer Advances's revenue is <$5 Million
What is Cancer Advances's SIC code?
Cancer Advances's SIC: 28,283
What is Cancer Advances's NAICS code?
Cancer Advances's NAICS: 32,325
How many employees does Cancer Advances have?
Cancer Advances has 11-50 employees
What industry does Cancer Advances belong to?
Cancer Advances is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Cancer Advances competition?
Cancer Advances top competitors include: Implicit Bioscience, JoMoCo, LifeMax Laboratories, Bcn Biosciences
What technology does Cancer Advances use?
Some of the popular technologies that Cancer Advances uses are: WooCommerce, WordPress.org, PHP, Google Font API
Who is the CFO of Cancer Advances?
Cancer Advances's CFO is John Wingen
What does Cancer Advances do?

Cancer Advances is dedicated to developing therapeutics for gastrin/gastrin receptor (CCKB) producing tumors, with a focus on improving the quality of life and extending survival for patients with gastrointestinal cancers. Their lead product, Polyclonal Antibody Stimulator (PAS), is an immunomodulator that inhibits gastrin function, slowing tumor g... rowth and altering the tumor microenvironment. The company is also exploring the synergy between PAS and PD-1 Checkpoint Inhibitors to enhance treatment efficacy. Cancer Advances aims to pioneer new medicines and redefine possibilities for cancer patients.Read More

What are Cancer Advances social media links?
Cancer Advances Linkedin page
Is Cancer Advances a public company?
Cancer Advances is private company therefore does not currently have an official ticker symbol
See more information about Cancer Advances

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.